Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: A dose-response effect dependent on endothelial nitric oxide synthase

International Journal of Cardiology

Volumn 131, Issue 3, 2009, Pages 313-320

  Chen, Hong ^a   Ren, Jing Yi ^a   Xing, Yan ^a   Zhang, Wan Lei ^a   Liu, Xin ^a   Wu, Pei ^a   Wang, Ruo Jie ^a   Luo, Yu ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Coronary artery disease; Endothelial function; Nitric oxide; Simvastatin

Indexed keywords

CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; NITRIC OXIDE; NITRITE; SIMVASTATIN;

ADULT; ARTICLE; BLOOD VESSEL INJURY; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DRUG WITHDRAWAL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; ULTRASOUND; UMBILICAL VEIN; VASODILATATION;

ADULT; ANTILIPEMIC AGENTS; CELLS, CULTURED; CORONARY ARTERY DISEASE; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RNA, MESSENGER; SIMVASTATIN; UMBILICAL VEINS; VASODILATION;

EID: 58149314288     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.10.044     Document Type: Article

References (19)

1. Almuti K., Rimawi R., Spevack D., and Ostfeld R.J. Effects of statins beyond lipid lowering: potential for clinical benefits. Int J Cardiol 109 (2006) 7-15
2. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 109 (2004) III-39-43 (Suppl III)
3. Simons L.A., Levis G., and Simons J. Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust 164 (1996) 208-211
4. Thomas M., and Mann J. Increased thrombotic vascular events after change of statin. Lancet 352 (1998) 1830
5. Heeschen C., Hamm C.W., Laufs U., Snapinn S., Bohm M., and White H.D. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 105 (2002) 1446-1452
6. Heeschen C., Hamm C.W., Laufs U., Bohm M., Snapinn S., and White H.D. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 107 (2003) e27. Letter
7. McGowan M.P. Treating to New Target (TNT) Study Group. There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients. Circulation 110 (2004) 2333-2335
8. Liao J.K. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol 96 (2005) 24F-33F
9. Chen H., Ikeda U., Shimpo M., and Shimada K. Direct effects of statins on cells primarily involved in atherosclerosis. Hypertens Res 23 (2000) 187-192
10. Laufs U., Wassmann S., Hilgers S., Ribaudo N., Böhm M., and Nickenig G. Rapid effects on vascular function after initiation and withdrawal of atorvastastin in healthy, normocholesterolemic men. Am J Cardiol 88 (2001) 1306-1307
11. Brandes R.P., Beer S., Ha T., and Busse R. Withdrawal of cerivastatin induces monocyte chemoattractant protein 1 and tissue factor expression in cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23 (2003) 1794-1800
12. Corretti M.C., Anderson T.J., Benjamin E.J., et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
13. Jaffe E.A., Nachman R.L., and Merskey C. Thrombotic thrombocytopenic purpura coagulation parameters in twelve patients. Blood 42 (1973) 499-507
14. Chen H., Ikeda U., Shimpo M., Ikeda M., Minota S., and Shimada K. Fluvastatin upregulates inducible nitric oxide synthase expression in cytokine-stimulated rat vascular smooth muscle cells. Hypertension 36 (2000) 923-928
15. Spencer F.A., Fonarow G.C., Frederick P.D., et al. National Registry of Myocardial Infarction. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction. Arch Intern Med 164 (2004) 2162-2168
16. de Jongh S., Lilien M.R., op't Roodt J., Stroes E.S., Bakker H.D., and Kastelein J.J. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol 40 (2002) 2117-2121
17. Beckman J.A., Liao J.K., Hurley S., et al. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Circ Res 95 (2004) 217-223
18. Laufs U., Endres M., Custodis F., et al. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 102 (2000) 3104-3110
19. Gertz K., Laufs U., Lindauer U., et al. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke 34 (2003) 551-557